Eligo Bioscience

Created in 2014

Country France France

Website http://eligo-bioscience.com/


Eligo Bioscience

Eligo Bioscience (France) develops a synthetic biology platform, which combines CRISPR/Cas system with engineered phage capsids, to develop “eligobiotics”: a new generation of highly precise antimicrobials. The Company can program eligobiotics to eliminate harmful bacteria based on the genetic sequences they carry in their genome while sparing the beneficial ones.